Workflow
cbdMD(YCBD)
icon
Search documents
cbdMD Announces Additional Conversions of Its Convertible Notes
Newsfile· 2025-01-08 22:22
cbdMD Announces Additional Conversions of Its Convertible NotesJanuary 08, 2025 5:22 PM EST | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has reduced the principal amount outstanding on its Senior Secured Convertible Not ...
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
Newsfile· 2025-01-03 21:44
Company Compliance Issues - cbdMD received a notice from NYSE American on December 31, 2024, stating noncompliance with Section 1003(a)(i) of the NYSE American Company Guide due to stockholders' equity of $1,963,417 as of September 30, 2024, which is below the required $2 million [1] - The company reported losses from continuing operations and/or net losses in four of its five most recent fiscal years [1] - cbdMD remains subject to a compliance plan accepted by NYSE American on August 20, 2024, to address noncompliance under Section 1003(a)(ii) due to stockholders' equity under $4 million [2] - The company must regain compliance by December 5, 2025, or face delisting procedures [2] Stock Listing and Trading - The notice has no immediate impact on the listing of cbdMD's common stock (YCBD) or Series A Preferred Stock (YCBD-PA), which will continue to trade on NYSE American during the compliance plan period [3] - Both stocks will trade with the designation "BC" to indicate "below compliance" status [3] Financial Performance and Strategy - cbdMD reduced cash consumption from $4.9 million in fiscal 2023 to approximately $0.7 million in fiscal 2024, with a significant reduction in the second half of fiscal 2024 [4] - The company is considering transactions, including converting Preferred Stock and its accrued dividend ($4.67 million as of September 30, 2024) into Common Stock, to increase stockholders' equity [4] Company Overview - cbdMD is a leading CBD company with brands including cbdMD, Paw CBD, and ATRx Labs, offering a comprehensive line of THC-free CBD products and Full Spectrum products [5][6] - The company's products include CBD tinctures, gummies, topicals, capsules, sleep aids, and Farm Act compliant Delta 9 products, as well as pet products and functional mushroom support [6]
cbdMD Announces Company's CEO Joins the Board of Directors
Newsfile· 2024-12-23 20:52
cbdMD Announces Company's CEO Joins the Board of DirectorsDecember 23, 2024 3:52 PM EST | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that T. Ronan Kennedy, the Company's Chief Executive Officer and Chief Financial Officer, has been ap ...
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
Newsfile· 2024-12-18 21:08
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss ImprovementFinishes the year with a stronger cash position.December 18, 2024 4:08 PM EST | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs toda ...
cbdMD(YCBD) - 2024 Q4 - Annual Report
2024-12-18 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | ...
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Newsfile· 2024-12-18 16:04
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 ResultsDecember 18, 2024 11:04 AM EST | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's ...
cbdMD, Inc. Reschedules Earnings Release and Conference Call
Newsfile· 2024-12-17 21:42
cbdMD, Inc. Reschedules Earnings Release and Conference CallDecember 17, 2024 4:42 PM EST | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - December 17, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and fiscal year ended September 30, 2024, which had previously been scheduled for December 17, 2024. cbdMD currently expects to issue its fourt ...
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Newsfile· 2024-12-12 17:12
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 ResultsDecember 12, 2024 12:13 PM EST | Source: cbdMDCharlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, December 17, 2024, to discuss the company's Se ...
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Newsfile· 2024-08-26 20:25
. ● . cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American August 26, 2024 4:25 PM EDT | Source: cbdMD Charlotte, North Carolina--(Newsfile Corp. - August 26, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, today announced that it received notice from the NYSE American LLC that it ha ...
cbdMD(YCBD) - 2024 Q3 - Earnings Call Transcript
2024-08-15 02:00
cbdMD, Inc. (NYSE:YCBD) Q3 2024 Earnings Conference Call August 14, 2024 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Chief Executive Officer & Chief Financial Officer Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. June 30, 2024 Third Fiscal 2024 Quarter and Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its third quarter results, which followed ...